Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro

British Journal of Pharmacology

Volumn 129, Issue 5, 2000, Pages 1021-1027

  Gandossi, E ^a   Lunven, C ^a   Berry, C N ^a  

^a SANOFI   (France)

Author keywords

Cell proliferation; Fibrin clots; Mitogen; Thrombin inhibitors

Indexed keywords

ANTITHROMBIN III; CHLOROMETHYL KETONE; FIBRIN; MITOGENIC AGENT; RECOMBINANT HIRUDIN; THROMBIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD CLOT; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTICOAGULANTS; ANTITHROMBIN III; ANTITHROMBINS; BLOOD COAGULATION; CELL DIVISION; CELL LINE; CRICETINAE; CRICETULUS; FIBRIN; FIBROBLASTS; HEPARIN; HIRUDINS; MALE; RABBITS; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; THROMBIN;

EID: 0034092826     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703137     Document Type: Article

References (40)

1. Arocas, V., Zingali, R.B., Guillin, M.-C., Bon, C. & Jandrot-Perrus, M. (1996). Bothrojaracin: a potent two-site-dírected thrombin inhibitor. Biochemistry, 35, 9083-9089.
2. Bahou, W.F., Coller, B.S., Potter, C.L., Norton, K.J., Kutok, J.L. & Goligorsky, M.S. (1993). The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J. Clin. Invest., 91, 1405-1413.
3. Bar Shavit, R., Benezra, M., Sabbah, V., Bode, W. & Vlodavsky, I. (1992). Thrombin as a multifunctional protein: induction of cell adhesion and proliferation. Am. J. Respir. Cell. Mol. Biol., 6, 123-130.
4. Berk, B.C., Taubman, M.B., Griendling, K.K., Cragoe, E.J.J., Fenton, J.W. & Brock, T.A. (1991). Thrombin-stimulated events in cultured vascular smooth-muscle cells. Biochem. J., 274, 799-805.
5. Berry, C.N., Girardot, C., Lecoffre, C. & Lunven, C. (1994). Effects of the synthetic thrombin inhibitor argatroban on fibrinor clot-incorporated thrombin: Comparison with heparin and recombinant hirudin. Thromb. Haemost., 72, 381-386.
6. Brown, L.F., Lanir, N., McDonagh, J., Tognazzi, K., Dvorak, A.M. & Dvorak, H.F. (1993). Fibroblast migration in fibrin gel matrices. Am. J. Pathol., 142, 273-283.
7. Chambard, J.C., Paris, S.L., Allemain, G. & Pouyssegur, J. (1987). Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin. Nature, 326, 800-803.
8. Farrell, D.H. & Al-Mondhiry, H.A. (1997). Human fibroblast adhesion to fibrinogen. Biochemistry, 36, 1123-1128.
9. Fenton II, J.W. (1995). Thrombin functions and antithrombotic intervention. Thromb. Haemostas., 74, 493-498.
10. Fenton II, J.W., Ofusu, F.A., Moon, D.G. & Maraganore, J.M. (1991). Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagulation and Fibrinolyais, 2, 69-75.
11. Francis, C.W., Markham, R.E.J., Barlow, G.H., Florack, T.M., Dobrzynski, D.M. & Marder, V.J. (1983). Thrombin activity of fibrin thrombi and soluble plasmic derivatives. J. Lab. Clin. Med., 102, 220-230.
12. Gallo, R., Padurean, A., Toschi, V., Bichler, J., Fallon, J.T., Chesebro, J., Fuster, V. & Badimon, J.J. (1998). Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation, 97, 581-588.
13. Gandossi, E., Lunven, C., Gauffeny, C., Roome, N.O. & Berry, C.N. (1998). Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors. Thromb. Haemost., 80, 840-844.
14. Gast, A., Tschopp, T.B., Schmid, G., Hilpert, K. & Ackermann, J. (1994). Inhibition of clot-bound and free (fluid-phase thrombin) by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma. Blood Coagul. Fibrinolysis, 5, 879-887.
15. Gimple, L., Gertz, S., Haber, H., Ragosta, M., Powers, E., Roberts, W. & Sarembock, I. (1992). Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. A quantitative angiographic and histopathological study. Circulation, 86, 1536-1546.
16. Goligorsky, M.S., Menton, D.N., Laszlo, A. & Lum, H. (1989). Nature of thrombin-induced sustained increase in cytosolic calcium concentration in cultured endothelial cells. J. Biol. Chem., 264, 16771-16775.
17. Greiling, D. & Clark, R.A. (1997). Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J. Cell. Sci., 110, 861-870.
18. Ishihara, H., Connolly, A.J., Zeng, D.W., Kahn, M.L., Zheng, Y.W., Timmons, C., Tram, T. & Coughlin, S.R. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-506.
19. Jaffe, E., Grulich, J., Weksler, B., Hampel, G. & Watanabe, K. (1987). Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J. Biol. Chem., 262, 8557-8565.
20. Kasai, S., Kunimoto, T. & Nitta, K. (1983). Cross linking of fibrin by activated factor XIII stimulates attachment, morphological changes and proliferation of fibroblasts. Biomed. Res., 4, 155 160.
21. 2Cl A selective affinity label for thrombin. Thromb. Res., 14, 969-973.
22. Kumar, R., Beguin, S. & Hemker, H.C. (1994). The influence of fibrinogen and fibrin thrombin generation. Evidence for feedback activation of the clotting system by clot bound thrombin. Thromb. Haemost., 72, 713-721.
23. Kumar, R., Beguin, S. & Hemker, H.C. (1995). The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb. Haemost., 74, 962-968.
24. Lunven, C., Gauffeny, C., Lecoffre, C., O'Brien, D.P., Roome, N.O. & Berry, C.N. (1996). Inhibition by argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin. Thromb. Haemost., 75, 154-160.
25. McNamara, C.A., Sarembock, I.J., Gimple, L.W., Fenton, J.W., Coughlin, S.R. & Owens, G.K. (1993). Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor (see comments). J. Clin. Invest., 91, 94-98.
26. Mirshahi, M., Soria, J., Soria, C., Faivre, R., Lu, H., Courtney, M., Roitsch, C., Tripier, D. & Caen, J.P. (1989). Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. Blood, 74, 1025-1030.
27. Rasmussen, U.B., Vouret Craviari, V., Jallat, S., Schlesinger, Y., Pages, G., Pavirani, A., Lecocq, J.P., Pouyssegur, J. & Van Obberghen Schilling, E. (1991). cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett., 288, 123-128.
28. Sarembock, I., Gertz, S., Gimple, L., Owen, R., Powers, E. & Roberts, W. (1991). Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation, 84, 232-243.
29. Schwarz, R.S., Holder, D.J., Holmes, D.R., Veinot, J.P., Carnrud, A.R., Jorgenson, M.A. & Johnson, R.G. (1996). Neointimal thickening after severe coronary artery injury is limited by a short term administration of a factor Xa inhibitor: results in a porcine model. Circulation, 93, 1542-1548.
30. Serruys, P.W., Herrman, J.P., Simon, P., Rutsch, W., Bode, C., Laarman, G.J., Van Dijk, R., Van Den Bos, A.A., Umans, V.A., Fox, K.A., Close, P. & Deckers, J.W. for the Helvetica Investigators. (1995). A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. New Engl. J. Med., 333, 757-763.
31. Shats, E.A., Nair, C.H. & Dhall, D.P. (1997). Interaction of endothelial cells and fibroblasts with modified fibrin networks: role in atherosclerosis. Atherosclerosis, 129, 9-15.
32. Sporn, L.A., Bunce, L.A. & Francis, C.W. (1995). Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood, 86, 1802-1810.
33. Tcheng, J.E. (1997). Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology. Thromb. Haemost., 78, 205-209.
34. Ueyama, M. & Uramaya, T. (1978). The role of factor XIII in fibroblast proliferation. Jpn. J. Exp. Med., 48, 135-142.
35. Vu, T.K., Hung, D., Wheaton, V.I. & Coughlin, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolylic mechanism of receptor activation. Cell, 64, 1057-1068.
36. Walters, T.K., Gorog, D.A. & Wood, R.F. (1994). Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J. Vasc. Res., 31, 173-177.
37. Weitz, J.I., Hudoba, M., Masel, D., Maraganore, J. & Hirsh, J. (1990). Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III independent inhibitors. J. Clin. Invest., 86, 385-391.
38. Weitz, J.I., Leslie, B. & Hudoba, M. (1998). Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors. Circulation, 97, 544-552.
39. Xu, W.F., Andersen, H., Whitmore, T.E., Presnell, S.R , Yee, D.P., Ching, A., Gilbert, T., Davie, E.W & Foster, D.C. (1998). Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U.S.A., 95, 6642-6646.
40. Zhong, C., Hayzer, D.J., Corson, M.A. & Runge, M.S. (1992). Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor. J. Biol. Chem., 267, 16975-16979.